Individualized treatment for tobacco dependence in addictions treatment settings: The role of current depressive symptoms on outcomes at 3 and 6 months

Nicotine and Tobacco Research

Volumn 17, Issue 8, 2015, Pages 937-945

  Zawertailo, Laurie A ^a,b   Baliunas, Dolly ^a   Ivanova, Anna ^a   Selby, Peter L ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT PLANNING; BEHAVIOR, ADDICTIVE; FOLLOW UP; LONGITUDINAL STUDY; MIDDLE AGED; ONTARIO; PERSONALIZED MEDICINE; PROCEDURES; PSYCHOLOGY; SMOKING; SMOKING CESSATION; TIME FACTOR; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; BEHAVIOR, ADDICTIVE; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ONTARIO; PRECISION MEDICINE; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84939482154     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv013     Document Type: Article

References (34)

1. Fiore M, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: U.S. Public Health Service; 2008.
2. DATIS. Substance Abuse Statistical Tables: Drug and Alcohol Treatment Information System. Centre for Addiction and Mental Health, Toronto, Canada, 2013.
3. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275:1097-1103.
4. Bobo JK, McIlvain HE, Lando HA, Walker RD, Leed-Kelly A. Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community intervention trial. Addiction. 1998;93:877-887.
5. Frosch DL, Shoptaw S, Nahom D, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol. 2000;8:97-103.
6. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72:1144-1156.
7. Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004;65:681-691.
8. Ait-Daoud N, Lynch WJ, Penberthy JK, Breland AB, Marzani-Nissen GR, Johnson BA. Treating smoking dependence in depressed alcoholics. Alcohol Res Health. 2006;29:213-220.
9. Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend. 2006;83:73-78.
10. Haas AL, Munoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol. 2004;72:563-570.
11. Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull. 2003;129:270-304.
12. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606-2610.
13. Tsuang MT, Francis T, Minor K, Thomas A, Stone WS. Genetics of smoking and depression. Hum Genet. 2012;131:905-915.
14. John U, Meyer C, Rumpf HJ, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity-a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004;76:287-295.
15. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry. 1998;55:161-166.
16. Shiffman S. Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol. 1982;50:71-86.
17. Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;28:660-666.
18. Munoz RF, Marin BV, Posner SF, Perez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol. 1997;25:325-343.
19. Gershon Grand RB, Hwang S, Han J, George T, Brody AL. Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness. J Clin Psychiatry. 2007;68:892-898; quiz 980-891.
20. Cook J, Spring B, McChargue D, Doran N. Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report. Nicotine Tob Res. 2010;12:978-982.
21. Leventhal AM, Piper ME, Japuntich SJ, Baker TB, Cook JW. Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol. 2014;82:122-129.
22. Hitsman B, Papandonatos GD, McChargue DE, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108:294-306.
23. Fuller BE, Guydish J, Tsoh J, et al. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2007;32:53-60.
24. Knudsen HK, Studts JL, Boyd S, Roman PM. Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. J Addict Dis. 2010;29:294-305.
25. Perka EJ Jr. Culture change in addictions treatment: a targeted training and technical assistance initiative affects tobacco-related attitudes and beliefs in addiction treatment settings. Health Promot Pract. 2011;12(suppl 2):159S-165S.
26. Herie M, Connolly H, Voci S, Dragonetti R, Selby P. Changing practitioner behavior and building capacity in tobacco cessation treatment: the TEACH project. Patient Educ Couns. 2012;86:49-56.
27. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737-1744.
28. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol. 2000;183:759-769.
29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
30. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5:13-25.
31. Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;28:660-666.
32. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;96:1808-1814.
33. Brown RA, Kahler CW, Niaura R, et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001;69:471-480.
34. Khara M, Okoli CT. The tobacco-dependence clinic: intensive tobaccodependence treatment in an addiction services outpatient setting. Am J Addict. 2011;20:45-55.